NEJM publishes Phase III SCENESSE studies
Filed with ASX ·
6ix hasn’t read this filing yet.
Clinuvel Pharmaceuticals Limited on 6ix
Later from Clinuvel Pharmaceuticals
- US FDA orphan designation received for cutaneous porphyrias
- Clinuvel brief on European commercialisation
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals